Anti cancer drugs breast anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Neoplastic Stem Cells Cell Line HCT116 Cells HT29 Cells Mammary Glands, Human

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases41

Neoplasms Radiation Injuries Carcinoma, Ductal, Breast Breast Diseases Breast Neoplasms Prostatic Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Ovarian Neoplasms Colonic Neoplasms Lung Neoplasms Neoplasms, Radiation-Induced Breast Neoplasms, Male Carcinoma Stomach Neoplasms Radiation Injuries, Experimental Radiation Pneumonitis Pancreatic Neoplasms Neoplasm Recurrence, Local Fibrocystic Breast Disease Adenocarcinoma Disease Progression Genetic Predisposition to Disease Carcinoma, Squamous Cell Carcinoma, Intraductal, Noninfiltrating Mammary Neoplasms, Experimental Uterine Cervical Neoplasms Carcinoma, Non-Small-Cell Lung Cell Transformation, Neoplastic Carcinoma, Lobular Colorectal Neoplasms Neovascularization, Pathologic Neoplasms, Experimental Neoplasms, Hormone-Dependent Head and Neck Neoplasms Bone Neoplasms Brain Neoplasms Urinary Bladder Neoplasms Liver Neoplasms Neoplasms, Second Primary Rectal Neoplasms

Chemicals and Drugs68

Antineoplastic Agents Doxorubicin Cisplatin Neoplasm Proteins Antineoplastic Agents, Phytogenic Drug Carriers Tumor Markers, Biological Drugs, Investigational Receptors, Estrogen Antibiotics, Antineoplastic Receptor, erbB-2 P-Glycoprotein Enzyme Inhibitors Tamoxifen Protein Kinase Inhibitors Naphthoquinones Fluorouracil RNA, Messenger Receptors, Progesterone Tumor Suppressor Protein p53 Paclitaxel Radiation-Sensitizing Agents DNA, Neoplasm RNA, Small Interfering Camptothecin Pyrimidines Antibodies, Monoclonal Plant Extracts Antineoplastic Agents, Hormonal Etoposide Piperazines Ellipticines Antimetabolites, Antineoplastic Anticarcinogenic Agents DNA Cancer Vaccines Benzamides Taxoids Angiogenesis Inhibitors DNA-Binding Proteins Proto-Oncogene Proteins c-bcl-2 Prodrugs Tumor Suppressor Proteins Antigens, Neoplasm DNA Adducts Receptor, Epidermal Growth Factor Organoplatinum Compounds Deoxycytidine Proto-Oncogene Proteins c-abl Caspases Estrogens Radiation-Protective Agents BRCA1 Protein Caspase 3 Estrogen Receptor alpha BRCA2 Protein Cyclophosphamide Protein-Serine-Threonine Kinases Antibodies, Monoclonal, Humanized DNA Topoisomerases, Type II RNA, Neoplasm Vinblastine Topoisomerase I Inhibitors Mitoxantrone Platinum Proto-Oncogene Proteins c-akt Antineoplastic Agents, Alkylating Nuclear Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment71

Radiation Dosage Drug Screening Assays, Antitumor Dose-Response Relationship, Radiation Drug Delivery Systems Drug Design Drug Discovery Molecular Targeted Therapy Xenograft Model Antitumor Assays Radiation Monitoring Inhibitory Concentration 50 Drug Carriers Clinical Trials as Topic Drug Approval Early Detection of Cancer Blotting, Western Gene Expression Profiling Mammography Prognosis Antineoplastic Combined Chemotherapy Protocols Radiotherapy Drug Evaluation, Preclinical Combined Modality Therapy Models, Biological Neoplasm Staging Neoplasm Transplantation Survival Analysis Reverse Transcriptase Polymerase Chain Reaction Models, Molecular Retrospective Studies Radiotherapy Dosage Radiation Injuries, Experimental Follow-Up Studies Survival Rate Transplantation, Heterologous Chemotherapy, Adjuvant Risk Factors Treatment Outcome Mastectomy Disease-Free Survival Immunohistochemistry Tumor Burden Prospective Studies Risk Breast Self-Examination Radiometry Mammary Neoplasms, Experimental Risk Assessment Breast Implants Sensitivity and Specificity Transfection Radiotherapy, Adjuvant Oligonucleotide Array Sequence Analysis Flow Cytometry Neoplasms, Experimental Mastectomy, Segmental Reproducibility of Results Registries Odds Ratio Polymerase Chain Reaction Multivariate Analysis Ultrasonography, Mammary Incidence Kaplan-Meier Estimate Immunoenzyme Techniques SEER Program Tumor Stem Cell Assay Drug Administration Schedule Magnetic Resonance Spectroscopy Gene Knockdown Techniques Phytotherapy Dose Fractionation

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes56

Radiation Dosage Radiation, Ionizing Drug Resistance, Neoplasm Dose-Response Relationship, Radiation Radiation Tolerance Apoptosis Gene Expression Regulation, Neoplastic Radiation Cell Proliferation Cell Survival Drug Resistance, Multiple Inhibitory Concentration 50 Molecular Structure Dose-Response Relationship, Drug Cell Cycle Breast Feeding Signal Transduction Time Factors DNA Damage Gamma Rays Cosmic Radiation Cell Division Mutation Drug Synergism Structure-Activity Relationship Genetic Predisposition to Disease Risk Down-Regulation Ultraviolet Rays Genes, BRCA1 Background Radiation DNA Repair Base Sequence Sensitivity and Specificity Transfection Protein Binding Cell Growth Processes Postmenopause Up-Regulation RNA Interference Cell Movement DNA Adducts Phosphorylation Gene Expression Odds Ratio Radiation Effects Promoter Regions, Genetic Cell Death Genes, p53 DNA Methylation Genes, BRCA2 Gene Silencing Premenopause Polymorphism, Genetic Stereoisomerism Genotype

Disciplines and Occupations6

Drug Design Drug Discovery Radiation Oncology Medical Oncology Immunohistochemistry Nanomedicine

Anthropology, Education, Sociology and Social Phenomena3

Drug Approval United States Food and Drug Administration National Cancer Institute (U.S.)

Technology, Industry, Agriculture3

Drug Industry Nanoparticles Nanomedicine

Information Science7

Survival Rate Pharmacopoeias as Topic Molecular Sequence Data Base Sequence Registries Incidence SEER Program

Named Groups1

Health Care34

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Clinical Trials as Topic Drug Costs United States Food and Drug Administration Fees, Pharmaceutical Survival Analysis Cosmic Radiation Retrospective Studies Radiation Injuries, Experimental Follow-Up Studies Survival Rate Risk Factors Treatment Outcome Disease-Free Survival Cost Sharing Prospective Studies Risk Ultraviolet Rays Risk Assessment National Cancer Institute (U.S.)Sensitivity and Specificity Age Factors Reproducibility of Results Registries Odds Ratio Radiation Effects Multivariate Analysis Incidence Kaplan-Meier Estimate SEER Program

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Antineoplastic Agents Breast Neoplasms Cell Line, Tumor Radiation Dosage Drug Screening Assays, Antitumor Radiation, Ionizing Drug Resistance, Neoplasm Radiation Injuries Dose-Response Relationship, Radiation Carcinoma, Ductal, Breast Radiation Tolerance Apoptosis Breast Diseases Gene Expression Regulation, Neoplastic Drug Delivery Systems Drug Design Drug Discovery Mice, Nude Radiation Cell Proliferation Molecular Targeted Therapy Cell Survival Tumor Cells, Cultured Radiation Protection Xenograft Model Antitumor Assays Breast Neoplasms Doxorubicin Radiation Monitoring Cisplatin Neoplasm Proteins Antineoplastic Agents, Phytogenic Drug Resistance, Multiple Prostatic Neoplasms Inhibitory Concentration 50 Drug Carriers Clinical Trials as Topic Drug Approval Tumor Markers, Biological Drugs, Investigational Receptors, Estrogen Molecular Structure Neoplasm Metastasis Dose-Response Relationship, Drug Neoplasm Invasiveness Cell Cycle Ovarian Neoplasms Breast Feeding Early Detection of Cancer Antibiotics, Antineoplastic Signal Transduction Colonic Neoplasms Lung Neoplasms Blotting, Western Receptor, erbB-2 Radiation Oncology Medical Oncology P-Glycoprotein Gene Expression Profiling Time Factors Mammography Prognosis Drug Industry Antineoplastic Combined Chemotherapy Protocols Neoplasms, Radiation-Induced Radiotherapy Enzyme Inhibitors DNA Damage Breast Neoplasms, Male Tamoxifen United States Carcinoma Drug Costs Protein Kinase Inhibitors Drug Evaluation, Preclinical United States Food and Drug Administration Combined Modality Therapy Models, Biological Neoplasm Staging Naphthoquinones Fluorouracil RNA, Messenger Fees, Pharmaceutical Receptors, Progesterone Gamma Rays Neoplasm Transplantation Survival Analysis Reverse Transcriptase Polymerase Chain Reaction Tumor Suppressor Protein p53 MCF-7 Cells Cosmic Radiation Paclitaxel Models, Molecular Radiation-Sensitizing Agents Stomach Neoplasms Retrospective Studies Radiotherapy Dosage Radiation Injuries, Experimental Follow-Up Studies Survival Rate

No FAQ available that match "anti cancer drugs breast anticancer drugs or radiation"